Trial Profile
Prospective Randomized Study Comparing Ovarian Stimulation With Pergoveris Supported by a GnRH Agonist in a Long Protocol Versus Multidose GnRH Antagonist Regimen in Young Infertile Women Treated With ICS
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary) ; Follitropin alfa/lutropin alfa; Triptorelin
- Indications Infertility
- Focus Therapeutic Use
- 27 Apr 2017 Status changed from not yet recruiting to completed.
- 05 Apr 2012 New trial record